"Botox from snake venom" — a genuinely beautiful biomimetic story, and a legitimate cosmetic ingredient. Syn-Ake is a rarity in this register: a real, approved cosmetic peptide with a great origin tale and honest topical data — not a gray-market injectable. Three threads: (1) it's inspired by the ve
Syn-Ake is a synthetic cosmetic dipeptide with one of skincare's best origin stories: it mimics Waglerin-1, a muscle-paralyzing toxin from the venom of the Temple Viper, reimagined by Swiss chemists (Pentapharm, 2001; now dsm-firmenich) as a needle-free, topical "Botox alternative." Its mechanism is genuinely elegant — it acts as a reversible antagonist of the muscle nicotinic acetylcholine receptor (mnAChR), binding the receptor's ε-subunit to dampen the nerve signal that makes facial muscles contract, so expression lines relax and soften. It's a legitimate, approved cosmetic ingredient (topical, not injected) with real in-vitro and in-vivo data: it reduces muscle-cell contraction substantially in vitro, and clinical cosmetic testing shows visibly reduced wrinkle depth over ~28 days, with good skin tolerance and a reversible effect. The honest framing: it's milder than Botox and works on the look of dynamic (expression) wrinkles, not deep structural ones — and, like all topical "muscle-relaxing" peptides, how much reaches muscle is inherently limited. For this register it's notable as a beautiful biomimetic story AND a genuine legal-lane cosmetic — the kind of ingredient that's actually sellable, honestly, with appearance claims.
a legal, established cosmetic ingredient (topical), used in finished skincare worldwide under standard cosmetic regulation. This is a cosmetic, not a medicine — no injection, no systemic use.
An honest grade per outcome — drawn from the evidence, not any catalogue. Hype and undemonstrated marketing claims grade low.
A credentialed reviewer (PharmD / PhD / MD) will be named before this entry is finalised. Until then, treat it as a working draft. Last updated July 2026 (established cosmetic active; status stable).
Grades reflect the published evidence, not our interest. No dosing, reconstitution, or administration is published for research compounds — that restraint is deliberate.
A neutral reference and a lawful-lane shop. Registered in Spain. Information for those who seek it — never promotion.
This site provides neutral scientific reference and sells only products lawful in your region. Nothing here is medical advice, a recommendation, or an offer to supply unapproved medicines. No dosing or administration is published for research compounds. Cosmetic peptides per Regulation (EC) 1223/2009. Unapproved injectable peptides are neither sold nor advertised in the EU (Directive 2001/83/EC, Title VIII). © 2026 Vallydia SL — Registered in Spain.